Prevenzione primaria della malattia cardiovascolare: c’è bisogno di un’aspirina?
The efficacy of antiplatelet treatment with aspirin in the primary prevention of major cardiovascular events was questioned during 2018, following a new series of trials that we summarize here in a quick synoptic overview. The three studies involved are the ASPREE trial, the ASCEND study and the ARR...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AboutScience Srl
2019-09-01
|
| סדרה: | Giornale di Clinica Nefrologia e Dialisi |
| גישה מקוונת: | https://journals.aboutscience.eu/index.php/gcnd/article/view/535 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|